261 related articles for article (PubMed ID: 9401775)
21. Light/dark cycle manipulation influences mice behaviour in the elevated plus maze.
Clénet F; Bouyon E; Hascoët M; Bourin M
Behav Brain Res; 2006 Jan; 166(1):140-9. PubMed ID: 16165231
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
23. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
[TBL] [Abstract][Full Text] [Related]
24. Benzodiazepine-withdrawal-induced gastric emptying disturbances in rats: evidence for serotonin receptor involvement.
Bonnafous C; Lefevre P; Bueno L
J Pharmacol Exp Ther; 1995 Jun; 273(3):995-1000. PubMed ID: 7791133
[TBL] [Abstract][Full Text] [Related]
25. 5-HT receptor subtypes involved in the serotonin-induced inhibition of L-leucine absorption in rabbit jejunum.
Salvador MT; Rodríguez-Yoldi MC; Alcalde AI; Rodríguez-Yoldi MJ
Life Sci; 1997; 61(3):309-18. PubMed ID: 9217291
[TBL] [Abstract][Full Text] [Related]
26. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
27. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
28. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
Griebel G; Perrault G; Sanger DJ
Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
[TBL] [Abstract][Full Text] [Related]
30. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
Yamada J; Sugimoto Y; Yoshikawa T
Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
[TBL] [Abstract][Full Text] [Related]
31. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
32. Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice.
Artaiz I; Zazpe A; Del Río J
Behav Pharmacol; 1998 Mar; 9(2):103-12. PubMed ID: 10065930
[TBL] [Abstract][Full Text] [Related]
33. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
34. 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats.
Cervo L; Samanin R
Pharmacol Biochem Behav; 1995 Dec; 52(4):671-6. PubMed ID: 8587903
[TBL] [Abstract][Full Text] [Related]
35. An antagonistic 5-HT receptor system in the auricles of the systemic heart complex of Sepia officinalis L. (Cephalopoda) shows 5-HT1 and 5-HT4 subtype properties.
Lehr T; Schipp R
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jun; 138(2):213-9. PubMed ID: 15450869
[TBL] [Abstract][Full Text] [Related]
36. Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium.
Läer S; Remmers F; Scholz H; Stein B; Müller FU; Neumann J
Br J Pharmacol; 1998 Mar; 123(6):1182-8. PubMed ID: 9559903
[TBL] [Abstract][Full Text] [Related]
37. Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety.
Li H; Ohta H; Izumi H; Matsuda Y; Seki M; Toda T; Akiyama M; Matsushima Y; Goto Y; Kaga M; Inagaki M
Behav Brain Res; 2013 Jan; 237():325-32. PubMed ID: 23043971
[TBL] [Abstract][Full Text] [Related]
38. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
Ashby CR; Edwards E; Wang RY
Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
[TBL] [Abstract][Full Text] [Related]
39. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
Sánchez C
Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
[TBL] [Abstract][Full Text] [Related]
40. Modulation of 5-HT4 receptor function in the rat isolated ileum by fluoxetine: the involvement of endogenous 5-hydroxytryptamine.
Tuladhar BR; Costall B; Naylor RJ
Br J Pharmacol; 2002 May; 136(1):150-6. PubMed ID: 11976280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
